One study reported the relevant effect of YAP on the genesis of DLBCL and revealed the controlling action of insulin-like growth factor-1 receptor (IGF-1 R) on the Hippo/YAP system, proposing a new, possible therapeutic approach to cure DLBCL. The gene discussed is YAP1; the disease is diffuse large B-cell lymphoma.